feed,title,long_url,short_url
Benzinga,EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody,https://benzinga.com/general/biotech/23/04/31783350/exclusive-fda-grants-expedited-review-status-to-sab-biotherapeutics-influenza-antibody,https://da.gd/FI7N
